Glaucoma Clinical Trial
Official title:
Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG or PEX
Verified date | February 2020 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
It has been hypothesized that the biomechanical properties of the optic nerve head and/or
sclera play a role in the development of glaucoma. One approach of gaining insight into the
biomechanical properties of the eye by the means of clinical studies is based on the
Friedenwald equation, representing a pressure-volume relationship. This equation represents
the so called ocular rigidity, which expresses the elasticity of the globe.
In order to be able to solve the equation, measurements of fundus pulsation amplitude (FPA)
with laser interferometry and dynamic contour tonometric assessment of the pulse amplitude
(PA) have to be performed.
In addition choroidal thickness will be assessed with OCT before and after trabeculectomy,
since results in choroidal thickness measurements in patients with glaucoma are
controversial.
The focus of this study lies on the changes of ocular rigidity and choroidal thickness after
surgical trabeculectomy in patients with primary open angle glaucoma (POAG) or
pseudoexfoliation glaucoma (PEX).
Status | Completed |
Enrollment | 53 |
Est. completion date | June 8, 2017 |
Est. primary completion date | June 8, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Men and women aged over 18 years - Normal ophthalmic findings except POAG or Pseudoexfoliation glaucoma (PEX) - Patients scheduled for trabeculectomy Exclusion Criteria: - Participation in a clinical trial in the 3 weeks preceeding the study - Symptoms of a clinically relevant illness in the 3 weeks before the first study day - Presence or history of a severe medical condition that will interfere with the study aim as judged by the clinical investigator - Other types of glaucoma, such as pigmentary glaucoma, history of acute angle closure - History of previous glaucoma surgery - Postoperative IOP = 8 mmHg - Ocular inflammation or infection within the past 3 months - Topical treatment with any ophthalmic drug except anti-glaucomatous medication |
Country | Name | City | State |
---|---|---|---|
Austria | Department of Clinical Pharmacology, Medical University of Vienna | Vienna |
Lead Sponsor | Collaborator |
---|---|
Medical University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in ocular rigidity | Change in ocular rigidity after surgery | Baseline and 28±7 days postoperative | |
Secondary | Fundus pulsation amplitude | Baseline and 28±7 days postoperative | ||
Secondary | Ocular pulse amplitude | Baseline and 28±7 days postoperative | ||
Secondary | Mean arterial pressure | Baseline and 28±7 days postoperative | ||
Secondary | Pulse rate | Baseline and 28±7 days postoperative | ||
Secondary | Axial eye length | Baseline and 28±7 days postoperative | ||
Secondary | choroidal thickness | Baseline and 28±7 days postoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A |